Fenofibrate is a medication that helps control blood fat levels. In this trial, it is being studied to see if it can help preserve the function of insulin-producing cells (called beta cells) in the pancreas of children who have recently been diagnosed with type 1 diabetes. This medication typically helps lower triglycerides and cholesterol levels, but researchers are investigating if it might also help protect the cells that produce insulin in people with diabetes.

Type 1 Diabetes – A chronic condition where the immune system attacks and destroys insulin-producing beta cells in the pancreas. This results in the body producing little or no insulin, which is essential for regulating blood sugar levels. The condition typically develops during childhood or adolescence, causing increased thirst, frequent urination, hunger, fatigue, and weight loss. Over time, the pancreas produces less and less insulin as more beta cells are destroyed. The body’s inability to properly process glucose leads to higher than normal blood sugar levels.

Note: I’ve provided only the disease mentioned in the source data (Type 1 Diabetes), following the specified format and guidelines. The description focuses on what the disease is and how it progresses, avoiding treatment information and maintaining accessibility for non-medical readers.